pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
nesvategrast
nesvategrast [INN]
Diabetic Macular Edema
OcuTerra Therapeutics Inc
0
catalysts
Phase 2
nimacimab
Obesity
Cannabinoid receptor 1
$SKYE
Skye Bioscience, Inc.
0
catalysts
Phase 2
ninsipapogene sibarnarepvec
Head And Neck Squamous Cell Carcinoma (HNSC)
$HOOK
HOOKIPA Pharma Inc.
0
catalysts
← prev
page 42 of 50
next →
131
Pain
89
Neurology
1
Phase 2
nispomeben
nispomeben [INN]
Diabetic Neuropathic Pain
Novaremed AG
0
catalysts
Phase 2
nitroxoline
nitroxoline [INN]
Muscle Invasive Bladder Cancer (MIBC)
Asieris Pharmaceuticals (USA) Inc
0
catalysts
Phase 2
nivisnebart
Alzheimer's Disease
$ALEC
Alector, Inc.
0
catalysts
Phase 2
nomlabofusp
Friedreich Ataxia
$LRMR
Larimar Therapeutics, Inc.
0
catalysts
Phase 2
nulabeglogene autogedtemcel
Sickle Cell Disease
Kamau Therapeutics Inc
0
catalysts
Phase 2
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
0
catalysts
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYC
BICYCLE THERAPEUTICS PLC
0
catalysts
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
0
catalysts
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
0
catalysts
Phase 2
odafosfamide
odafosfamide [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
OBI Pharma Inc
0
catalysts
Phase 2
odatroltide
odatroltide [INN]
Acute Ischemic Stroke
Lumosa Therapeutics Co Ltd
0
catalysts
Phase 2
olafertinib
olafertinib [INN]
Non-Small Cell Lung Cancer
Checkpoint Therapeutics Inc
0
catalysts
Phase 2
olaptesed pegol
olaptesed pegol [INN]
Glioblastoma Multiforme (GBM)
TME Pharma AG
0
catalysts
Phase 2
olatorepatide
olatorepatide [INN]
Obesity
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 2
olisutrigine bromide
olisutrigine bromide [INN]
Pruritus
Formation Bio Inc
0
catalysts
Phase 2
omilancor
omilancor [INN]
Ulcerative Colitis
NImmune Biopharma Inc
0
catalysts
Phase 2
ompenaclid succinate
Metastatic Colorectal Cancer
Inspirna Inc
0
catalysts
Phase 2
onrogadgene parvec
Parkinson's Disease
$MGTX
MeiraGTx Holdings plc
0
catalysts
Phase 2
ontunisertib
Crohn's Disease (Regional Enteritis)
$AGMB
Agomab Therapeutics NV
0
catalysts
Phase 2
onvansertib fumarate
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$CRDF
Cardiff Oncology, Inc.
0
catalysts
Phase 2
onvapegleukin alfa
Cervical Cancer
Ascendis Pharma AS
0
catalysts
Phase 2
onzemipgene parvec
onzemipgene parvec [INN]
Dry (Atrophic) Macular Degeneration
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 2
opaganib
YELIVA (opaganib [INN])
Bile Duct Cancer (Cholangiocarcinoma)
$RDHL
RedHill Biopharma Ltd.
0
catalysts
Phase 2
ordastobart
Adenocarcinoma Of The Gastroesophageal Junction
$INBX
Inhibrx Biosciences, Inc.
0
catalysts
Phase 2
orismilast
orismilast [INN]
Plaque Psoriasis (Psoriasis Vulgaris)
Union Therapeutics AS
0
catalysts
Phase 2
orvacabtagene autoleucel
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0
catalysts
Phase 2
orvepitant
Chronic Cough
Substance-P receptor
NeRRe Therapeutics Ltd
0
catalysts
